Russia's Radiological, Chemical and Biological Defense (RCB) Troops began exposing the extent of the US bioweapons program in Ukraine last spring, using information obtained in the course of Moscow's special military operation in that country, launched on February 24, 2022.
US-funded biolabs pose a risk for the entire population of the planet associated with the potential spread of newly developed pathogens, Anna Popova, head of Russia's Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) agency, has stated.
“Of course there are risks of the spread of new, unknown, advanced pathogens out there. It is also remarkable that there are publications in which they openly state that they are studying pathogens and enhancing their properties. In my opinion, this is a clear violation of the convention (on biological weapons – ed.),” Anna Popova said.